According to the research literature titled ‘GLOBAL Injectable Drug Delivery Market 2019-2027’, available with Market Study Report, global injectable drug delivery market is projected to register a year-over-year growth rate of 8.67% CAGR during the forecast period 2019-2027.
 

Experts analysts cited that increasing elderly population and rising incidences of auto-immune diseases are catalyzing global injectable drug delivery market growth. Moreover, technological innovations in injectable systems is expected to present new growth avenues in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2519226/
 

On the contrary, high manufacturing costs, advancements in alternate, drug delivery systems, and stringent regulations are expected to be the major growth barriers for the industry over the projected timeline.
 

Based on device, global injectable drug delivery market is fragmented into auto-injector, pen injector, prefilled syringe, and needle-free injector. In terms of route of administration, the industry is split into intramuscular, subcutaneous, intravenous, and others. Moving on, end-user segmentation comprises ambulatory care, clinics/physician offices, home-based, hospital, and others.
 

Considering the geographical landscape, top contributors to the market expansion are North America (U.S., Canada), Asia Pacific (India, Japan, China, South Korea, ASEAN Countries Australia and New Zealand), Latin America (Brazil, Mexico), Europe (Russia, Germany, France, Italy, Spain, U.K.), and Middle East and Africa (Turkey, United Arab Emirates, Saudi Arabia, South Africa).
 

Asia-Pacific injectable drug delivery industry progression is anticipated to multiply at a significant pace during the forecast years, creditable to expanding geriatric populace, increase in life expectancy, and surge in demand for better healthcare products facilitated by rising per capita income.
 

Speaking of the competitive landscape, Ypsomed Holding AG, West Pharmaceutical Services, Inc., Teva Pharmaceutical Industries Ltd., Terumo Corp., Schott AG, Sanofi S.A., Pfizer, Inc., Novo Nordisk A/S, Novartis International AG, Injex, Gerresheimer AG, Eli Lilly and Company, Elcam Medical ACS. Ltd., Becton, Dickinson and Company, and Baxter International, Inc. are the top-tier players in global injectable drug delivery industry sphere.